Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00198471Phase 2Completed
Phase 2, open-label, single-arm trial of hyaluronidase (ovine) in diabetic retinopathy (DR), sponsored by Bausch + Lomb. Primary endpoint: Vitreous detachment at Day 28. Started Jul 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00198471.